申请人:PIERRE FABRE MEDICAMENT
公开号:US20160229834A1
公开(公告)日:2016-08-11
The present invention relates to compounds of the following formula (I): and pharmaceutically acceptable salts and solvates thereof, their methods of preparation, their use as a drug, notably in the treatment of cancer, and pharmaceutical compositions containing such compounds.
本发明涉及以下式(I)的化合物及其药学上可接受的盐和溶剂化物,其制备方法,其作为药物的用途,尤其是在癌症治疗方面的应用,以及含有这些化合物的药物组合物。